208:poster Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: an economic evaluation of the INTRO-HCV trial
oleh: Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes, Christer Frode Aas, Aaron G Lim, Ege Su Çağlar, Jørn-Henrik Vold
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2022-04-01 |
Deskripsi
No description available for this item.